Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases: From Mechanistic Insights to Biomarkers

Phase I/II clinical trials of autologous hematopoietic stem cell transplantation (AHSCT) have led to increased safety and efficacy of this therapy for severe and refractory autoimmune diseases (AD). Recent phase III randomized studies have demonstrated that AHSCT induces long-term disease remission...

Descripción completa

Detalles Bibliográficos
Autores principales: Malmegrim, Kelen Cristina Ribeiro, Lima-Júnior, João Rodrigues, Arruda, Lucas Coelho Marlière, de Azevedo, Júlia Teixeira Cottas, de Oliveira, Gislane Lelis Vilela, Oliveira, Maria Carolina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250746/
https://www.ncbi.nlm.nih.gov/pubmed/30505303
http://dx.doi.org/10.3389/fimmu.2018.02602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250746/
https://www.ncbi.nlm.nih.gov/pubmed/30505303
http://dx.doi.org/10.3389/fimmu.2018.02602

Ejemplares similares